Jesse Clark, MD, MSc

Jesse Clark, MD, MSc

Core Director, Development Core


Jesse Clark, MD, MSc, is Professor-in-Residence in the Department of Medicine, Division of Infectious Disease and Department of Family Medicine in the David Geffen School of Medicine at UCLA. His research addresses the integration of new prevention technologies within the social and sexual networks of Latin American and Latino MSM. He studied History and American Civilization at Brown University and Medicine at Albert Einstein College of Medicine, completed Internal Medicine Residency at Montefiore Medical Center, and Infectious Diseases Fellowship at UCLA. He is Director of the UCLA South American Program in HIV Prevention Research (SAPHIR) training program in Lima, Peru and Rio de Janeiro, Brazil and the UCLA T32 Post-Doctoral Fellowship in Global HIV Prevention and Treatment. Dr. Clark is also Medical Director for the UCLA Vine Street Clinic where he has led the site’s involvement in trials of long-acting injectable PrEP medications, mRNA vaccines to prevent COVID-19 and HIV-1, and studies of new therapeutics for substance use disorders. Current research includes: Expedited Partner Therapy (EPT) to promote partner notification following STI diagnosis; Integrated approaches to harm reduction among men engaged in Chemsex; and STI screening as HIV prevention among MSM in Peru.

Contact: jlclark@mednet.ucla.edu

FEATURED PUBLICATIONS:

1. Rush, C. R., Santos, G. M., McMahan, V. M., Fraser, A., Clark, J., Luna Marti, X., Walker, J. E., Shoptaw, S., & Coffin, P. O. (2025). Mirtazapine reduces hypothetical methamphetamine demand in humans. Drug and alcohol dependence, 274, 112769.

2. Yi, G., Javanbakht, M., Rosen, A. D., Gorbach, P., Clark, J., & Shoptaw, S. (2025). Speed and smoking kill: A time-varying survival analysis linking methamphetamine use, cigarette smoking, and mortality in sexual minority men. The International journal on drug policy, 143, 104874.

3. Riddler, S. A., Moodie, Z., Clark, J., Yen, C., Allen, M., Furch, B. D., Lu, H., Grant, S., Mondal, K., Anderson, M., Maenza, J., Lemos, M. P., Woodward Davis, A. S., Walsh, S. R., Sobieszczyk, M. E., Frank, I., Goepfert, P., Stephenson, K. E., Baden, L. R., Tieu, H. V., … Corey, L. (2025). High Frequency of Chronic Urticaria Following an Investigational HIV-1 BG505 MD39.3 Trimer mRNA Vaccine in a Phase 1, Randomized, Open-Label Clinical Trial (HVTN 302). Annals of internal medicine, 178(7), 963–974.

 

Last updated: 11/18/2025